Trials / Completed
CompletedNCT00395044
Gabapentin Treatment of Cannabis Dependence
Gabapentin for Cannabis Withdrawal and Use
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- The Scripps Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.
Detailed description
This is a 12-week, double blind, placebo controlled, dose ranging study to evaluate the efficacy of gabapentin in treating outpatients with cannabis dependence. Counseling and research assessments occur weekly throughout the 12-week treatment phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo |
| DRUG | Gabapentin |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2006-11-02
- Last updated
- 2017-02-10
- Results posted
- 2017-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00395044. Inclusion in this directory is not an endorsement.